Clinical trials
Active, not recruiting Observational trials in Austria
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
120 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2011 | 1 |
| 2013 | 5 |
| 2015 | 2 |
| 2016 | 3 |
| 2017 | 8 |
| 2018 | 7 |
| 2019 | 13 |
| 2020 | 10 |
| 2021 | 16 |
| 2022 | 6 |
| 2023 | 19 |
| 2024 | 14 |
| 2025 | 9 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 120 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Medical University of Graz | 7 |
| Medical University of Vienna | 7 |
| AbbVie | 4 |
| Medical University Innsbruck | 4 |
| Boston Scientific Corporation | 3 |
| Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company | 3 |
| Kepler University Hospital | 3 |
| Prim. Prof. Dr. Oliver Findl, MBA | 3 |
| University Hospital, Basel, Switzerland | 3 |
| Abbott Medical Devices | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Atrial Fibrillation | 6 |
| Colitis, Ulcerative | 5 |
| Aortic Dissection | 4 |
| Cardiovascular Diseases | 4 |
| Aortic Valve Stenosis | 3 |
| Breast Neoplasms | 3 |
| Peripheral Arterial Disease | 3 |
| Aortic Aneurysm | 2 |
| Aortic Aneurysm, Abdominal | 2 |
| Aortic Aneurysm, Thoracic | 2 |
Trials
Showing 1 to 25 of 120. Each trial links to its page on Pharma Observatory.
20 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.